Direct effects of gonadotropin releasing hormone on testicular Leydig cell functions.
D015113:Androstane-3,17-diol / Q000096:biosynthesis; D000818:Animals; D002478:Cells, Cultured; D004967:Estrogens / Q000096:biosynthesis; D005260:Female; D005640:Follicle Stimulating Hormone / Q000494:pharmacology; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives / Q000494:pharmacology; D006107:Granulosa Cells / Q000378:metabolism; D013006:Growth Hormone / Q000494:pharmacology; D007016:Hypophysectomy; D007700:Kinetics; D007985:Leydig Cells / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D010906:Pituitary Hormone-Releasing Hormones / Q000494:pharmacology*; D011388:Prolactin / Q000494:pharmacology; D051381:Rats; D011956:Receptors, Cell Surface / Q000378:metabolism; D011974:Receptors, LH; D013739:Testosterone / Q000096:biosynthesis*
D004967:Estrogens; D010906:Pituitary Hormone-Releasing Hormones; D011956:Receptors, Cell Surface; D011974:Receptors, LH; D015113:Androstane-3,17-diol; D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; C026680:LHRH, Leu(6)-Leu(N-alpha-Me)(7)-N-Et-ProNH2(9)-; D011388:Prolactin; D005640:Follicle Stimulating Hormone; D013006:Growth Hormone